Target intelligence / Profile preview

Mitochondrial respiratory chain complexes (Complexes I-V)

Target
Complexes I-V
Molecular classification
Enzyme
01

Overview

Mitochondrial respiratory chain complexes, also known as oxidative phosphorylation (OXPHOS) complexes I-V, are multienzyme assemblies embedded in the inner mitochondrial membrane that form the core of cellular energy production. They transfer electrons from NADH and FADH2 through a chain to oxygen, pumping protons to generate an electrochemical gradient that drives ATP synthesis by complex V (ATP synthase). Complex I (NADH:ubiquinone oxidoreductase) initiates the chain by oxidizing NADH and reducing ubiquinone while pumping protons; complex II (succinate dehydrogenase) feeds electrons from the TCA cycle; complex III (cytochrome bc1) and IV (cytochrome c oxidase) continue electron transfer and proton pumping; and complexes often assemble into respirasomes (supercomplexes) for efficient function and reduced ROS leakage. These complexes maintain redox balance but are major sites of reactive oxygen species (ROS) production when dysfunctional. Dysregulation impairs ATP production, elevates oxidative stress, and disrupts metabolism, contributing to diseases like neurodegenerative disorders (e.g., via complex I defects), liver pathologies (e.g., NAFLD, HCC), and cancer through bioenergetic failure and signaling alterations. While not typical monomeric drug targets like receptors or single enzymes, their subunits are implicated in mitochondrial diseases, with therapeutic interest in stabilizers or biogenesis modulators, though broad inhibition risks severe cytotoxicity due to universal energy dependence.

Other names
Oxidative phosphorylation (OXPHOS) complexeselectron transport chain (ETC) complexesrespiratory complexesrespirasomes (when assembled as supercomplexes)
02

Biological functions

ATP synthesis via oxidative phosphorylationelectron transfer from NADH/FADH2 to oxygenproton translocation across inner mitochondrial membranemaintenance of redox homeostasisROS generation and signaling
03

Disease associations

Neurodegenerative diseaseCancerCardiovascular diseaseLiver disease (e.g., NAFLD, alcoholic liver disease, hepatocellular carcinoma)InfectionMetabolic disorders
04

Safety considerations

Disruption leads to ATP depletionexcessive ROS production causing oxidative stressapoptosisredox imbalancemetabolic dysregulationpotential for on-target toxicity in high-energy tissues like liver, brain, heart
05

Biomarkers

Complex I activity levelsmtDNA mutations in complex subunits (e.g., ND genes)ROS production levelsrespiratory supercomplex assembly status

Beyond the preview

Go deeper on Mitochondrial respiratory chain complexes (Complexes I-V).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial respiratory chain complexes (Complexes I-V).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call